Department of Clinical Oncology, Army Medical Center, and.
Department of Respiratory and Critical Medicine, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
Am J Respir Cell Mol Biol. 2024 Dec;71(6):632-645. doi: 10.1165/rcmb.2023-0448TR.
The concurrence of chronic obstructive pulmonary disease (COPD) and lung cancer has been widely reported and extensively addressed by pulmonologists and oncologists. However, most studies have focused on shared risk factors, DNA damage pathways, immune microenvironments, inflammation, and imbalanced proteases/antiproteases. In the present review, we explore the association between COPD and lung cancer in terms of airway pluripotent cell fate determination and discuss the various cell types and signaling pathways involved in the maintenance of lung epithelium homeostasis and their involvement in the pathogenesis of co-occurring COPD and lung cancer.
慢性阻塞性肺疾病(COPD)和肺癌的并发已被肺病学家和肿瘤学家广泛报道和深入研究。然而,大多数研究集中在共同的风险因素、DNA 损伤途径、免疫微环境、炎症和失衡的蛋白酶/抗蛋白酶上。在本综述中,我们从气道多能细胞命运决定的角度探讨 COPD 和肺癌之间的关联,并讨论维持肺上皮细胞内稳态的各种细胞类型和信号通路及其在并发 COPD 和肺癌发病机制中的作用。